CLDN7 and clear cell renal carcinoma: also used immunohistochemistry and found that CLDN7 was expressed in 3.4% of renal clear cell carcinoma, 34.5% of renal papillary adenocarcinoma, and 95% of renal chromophobe carcinoma (154).